Lycopene Market Size, Share, Growth, and Industry Analysis, By Type (Synthetic Lycopene,Organic Lycopene), By Application (Cosmetics,Pharmaceutical,Food Coloring Agent), Regional Insights and Forecast to 2035
Lycopene Market Overview
The global Lycopene Market size is projected to grow from USD 179.13 million in 2026 to USD 188.27 million in 2027, reaching USD 280.28 million by 2035, expanding at a CAGR of 5.1% during the forecast period.
The lycopene market is witnessing robust interest in the B2B domain, as manufacturers across nutraceuticals, dietary supplements, food & beverage, and cosmetic industries integrate this red-pigmented carotenoid. In 2024 the market reached approximately USD 155 million, fuelled by over 60% of global consumers seeking antioxidant-rich ingredients. The market share for health-ingredient use exceeded 69% of total lycopene applications in 2024, signalling strong preference for wellness-oriented formulations.
Looking ahead, market opportunities emerge from B2B demand for natural and organic sources, with synthetic lycopene still holding approximately 57.9% share in 2024 due to cost and availability factors, while the natural segment is gaining traction. As companies in food colouring, personal care, and pharmaceuticals seek clean-label, plant-based ingredients, the lycopene market outlook is positive for those supplying to B2B channels.
From a B2B perspective, industry players should watch that in the period between 2025 and 2034 the market size is forecast to expand from about USD 155.0 million to USD 254.9 million, representing substantial market growth and strong market opportunities for ingredient suppliers, formulators, and manufacturers in the lycopene market sphere.
In the United States, the lycopene market registers a commanding lead within North America, accounting for roughly 30% of the regional share in 2023, translating to about USD 49.6 million of revenue from the market’s total USD 161 million global value in 2023. U.S. demand is driven by B2B customers—dietary supplement manufacturers, sports nutrition formulators and cosmetic ingredient sourcing companies—who are sourcing more than 40% of their antioxidant-ingredient procurement from lycopene-based derivatives in 2023. Regulatory standards and high per-capita consumption of nutraceuticals further bolster procurement and adoption. In 2024 the U.S. market segment for lycopene saw ingredient volumes used in food & beverage applications exceed 250 tonnes, marking a year-on-year increase of more than 8% compared to 2023.
Key Finding
- Key Market Driver: Approximately 69% of total lycopene application demand in 2024 was for health-ingredient use, driving market size upward in the lycopene market analysis and market growth.
- Major Market Restraint: About 57.9% of the lycopene market in 2024 was still driven by synthetic source, indicating limited access to natural source supply which restrains the natural lycopene segment in the market outlet.
- Emerging Trends: The beadlets form accounted for approximately 39.2% of total lycopene form segment in 2024, highlighting a trend toward improved stability and absorption in B2B formulations.
- Regional Leadership: North America held about 30.8% share of the global lycopene market in 2023, underscoring its regional leadership in the global lycopene market insight.
- Competitive Landscape: Synthetic lycopene maintained about 57.9% share in 2024, highlighting the dominance of cost-efficient manufacturers in the competitive lycopene market arena.
- Market Segmentation: Dietary supplements led the application with approximately 38.5% share in 2024, showing that the lycopene market segmentation is heavily tilted toward supplement usage.
- Recent Development: In 2024 the lycopene food colour segment was estimated at USD 114.0 million, with projection toward USD 314.9 million by 2035, indicating significant recent development in the lycopene market opportunity.
Lycopene Market Trends
The lycopene market displays clear signals of growth in the antioxidant ingredient sector, with approximately USD 161.9 million global market value in 2024 and projected to reach USD 254.2 million by 2033. For B2B markets, this suggests that ingredient suppliers and formulation houses are increasingly sourcing lycopene for functional foods, beverages, supplements and personal care. The powder form of lycopene dominated the form segment in 2023, indicating a preferred format for industrial use in bulk formulations. Manufacturers are favouring natural-source lycopene, driven by consumer demand for clean-label ingredients in the B2B supply chain; although synthetic remains dominant, the shift is measurable.
Lycopene Market Dynamics
In analysing the market dynamics for the lycopene industry, several forces shape the data. One, the growing incidence of lifestyle diseases such as prostate cancer (1.5 million new cases globally reported in 2019) fuels demand for antioxidant ingredients such as lycopene in the nutraceutical and pharmaceutical sectors. Two, the food & beverage industry is increasingly using lycopene as a natural colorant as well as health-ingredient, whereby the food colour applications market for lycopene is estimated at USD 114 million in 2025 rising toward USD 314.9 million by 2035. Three, cost and supply constraints: about 57.9% of lycopene in 2024 sourced synthetically due to lower cost, hindering the natural segment’s expansion.
DRIVER
"The driver for lycopene demand in the B2B market comes from the increasing health-conscious consumer base, "
Driving ingredient buyers to purchase antioxidant-rich materials: in 2024 about 69% of lycopene applications were for health-ingredient use. The increased usage of lycopene in dietary supplements, functional foods and preventive-health formulations positions it as a strategic ingredient for manufacturers sourcing at B2B scale. With over 38.5% of applications attributed to supplement usage in 2024, ingredient suppliers for lycopene are experiencing increased order volumes from supplement formulators.
RESTRAINT
"One major restraint impacting the lycopene market for B2B buyers and suppliers is the cost and availability of natural-source lycopene:"
in 2024 synthetic sources retained approximately 57.9% market share due to their lower production cost and simpler processing, leaving less than 42.1% for natural source, creating a supply constraint for formulators seeking natural or organic alternatives. Additionally, the requirement for high stability and shelf-life in industrial applications means that beadlets, oil suspension and powder forms account for large proportions of ingredient formats: the beadlets form held about 39.2% share in 2024, but achieving that requires investment in manufacturing technology and higher cost, limiting small-scale B2B ingredient producers.
OPPORTUNITY
"In the field of market research report and market opportunities, lycopene presents significant opportunity for B2B stakeholders: "
the global lycopene market size rose from about USD 148.33 million in 2024 to projected USD 210.94 million by 2032, reflecting a growth opportunity for ingredient suppliers, contract manufacturers and formulation services. Also, the food colour application segment for lycopene was valued at USD 114.0 million in 2025 and is forecast to reach USD 314.9 million by 2035, opening new opportunity verticals for food-colour suppliers and formulators in the lycopene market. Moreover, the rising demand for clean-label, plant-based ingredients in cosmetics and personal care provides a B2B sourcing window: the natural lycopene form is increasingly used in anti-ageing skincare and sun-protection formulations.
CHALLENGE
"For B2B participants tracking lycopene market research and industry analysis, a key challenge lies in stabilising lycopene in end-use formulations: "
Due to its sensitivity to heat, light and oxidation, achieving high bioavailability and shelf-life in industrial formats adds complexity. In one study the encapsulation efficiency in nanoparticles for lycopene reached 97% with extended sonication time but required specialised processes. Another challenge is sourcing natural-tomato-derived lycopene at scale: while global tomato production is high, converting raw material into high-purity lycopene for industrial use remains cost-intensive and requires controlled supply chains.
Lycopene Market Segmentation
In this market segmentation overview of the lycopene market, two major bases present themselves: by type (source) and by application. In the global lycopene market size of approximately USD 161.9 million in 2024, the synthetic lycopene source segment held roughly 57.9% share, while the natural source accounted for about 42.1% share, signifying strong preference shift and segmentation importance for B2B ingredient buyers. On the application side, the dietary supplement segment captured around 38.5% of total lycopene application share in 2024, while food & beverage, pharmaceutical and personal care segments filled the remainder, demonstrating how B2B manufacturers across these sectors segment their lycopene ingredient procurement.
BY TYPE
Synthetic Lycopene: Synthetic lycopene remains a major component of the lycopene market segment, commanding approximately 57.9% share of global market value in 2024. This is largely due to the lower cost of production and simpler processing compared to natural extraction. Lower raw-material volatility, standardised quality and broader availability make synthetic lycopene a preferred choice for many B2B ingredient users in food, pharmaceutical and cosmetic industries. Its dominance in the market size supports manufacturers and formulators who prioritise cost-efficiency and predictable supply.
The Synthetic Lycopene market was valued at USD 95 million in 2024, accounting for approximately 57% of the global share, and is projected to register a CAGR of 6.8% during the forecast period. This growth is primarily attributed to increasing demand in dietary supplements and food coloring applications across pharmaceutical and nutrition sectors.
Top 5 Major Dominant Countries in the Synthetic Lycopene Segment
- United States: With a market value of USD 30 million and a share of 31%, the United States maintains a CAGR of 6.9%. Robust food supplement demand, advanced production technology, and a thriving nutraceutical industry strengthen its leadership in the global synthetic lycopene segment.
- Germany: Germany’s market is valued at USD 15 million with a 16% share and a CAGR of 6.7%. The country benefits from advanced industrial biotechnology, strong cosmetic manufacturing capabilities, and regulatory support for synthetic antioxidants, enhancing domestic and export opportunities.
- China: China holds a USD 13 million market size with a 14% share and CAGR of 6.9%. Rapid industrialization, expanding dietary supplement production, and growing urban population health awareness boost steady market expansion and innovation in cost-efficient lycopene synthesis.
- Japan: With USD 12 million in market size, a 13% share, and CAGR of 6.8%, Japan demonstrates strong adoption in functional foods, beverages, and skincare products, driven by premium consumer health awareness and technological efficiency in extraction methods.
- India: India’s market, valued at USD 10 million (11% share) and CAGR 6.6%, benefits from expanding nutraceutical brands, government food fortification initiatives, and affordable synthetic ingredient manufacturing capacity to support domestic and export markets.
Organic Lycopene: The organic or natural type segment in the lycopene market held roughly 42.1% of global value in 2024, reflecting strong growth opportunities for ingredient suppliers specialising in tomato-based and plant-derived sources. B2B buyers in food & beverage, dietary supplements and personal care are increasingly specifying natural lycopene due to consumer demand for plant-based, clean-label ingredients. Although extraction costs and supply-chain complexities are higher, the value-addition is significant: natural lycopene often commands premium pricing, and its share is expanding.
The Organic Lycopene market was valued at USD 72 million in 2024, representing 43% of the total global market, and is expected to grow at a higher CAGR of 7.4% through 2032 due to rising consumer preference for natural, clean-label ingredients and sustainable extraction processes from tomatoes and other carotenoid sources.
Top 5 Major Dominant Countries in the Organic Lycopene Segment
- United States: The market value is USD 20 million with a share of 28% and a CAGR of 7.5%. Growth is propelled by the popularity of organic supplements, functional beverages, and cosmetic formulations emphasizing non-synthetic, naturally derived ingredients for health and wellness.
- Italy: With USD 14 million (19% share) and CAGR 7.3%, Italy benefits from advanced tomato-based lycopene extraction technology, organic farming practices, and extensive use in premium food and beauty applications.
- China: China’s organic lycopene market stands at USD 13 million (18% share) with CAGR 7.4%. Growing organic processing facilities, export-oriented production, and consumer preference for natural carotenoid supplements foster long-term industry expansion.
- Germany: The market value is USD 12 million (17% share) with a CAGR of 7.2%. Germany’s food and pharmaceutical manufacturers increasingly incorporate organic lycopene into antioxidant-rich products, enhancing competitiveness in the European market.
- India: Valued at USD 10 million (14% share) with a CAGR of 7.5%, India’s organic lycopene industry is driven by natural extraction techniques, health supplement proliferation, and rising consumer trust in clean-label nutraceuticals.
BY APPLICATION
Cosmetics: In the lycopene market application segmentation, cosmetics represent a growing channel for B2B ingredient sales—manufacturers of anti-ageing creams, sun-protection lotions and skin-care serums are sourcing lycopene as a red pigment and antioxidant. As the global consumer demand for natural and functional skin-care ingredients expands, the lycopene market trend shows cosmetics applications forming an increasing portion of the market size. Ingredient suppliers offering lycopene in formats amenable to skin-care formulations (e.g., powder, oil suspension) are meeting that B2B demand.
The Lycopene market in the cosmetics application was valued at USD 60 million in 2024, with a market share of 36% and a CAGR of 6.9%. The increasing use of lycopene as a natural antioxidant for skin protection, anti-aging creams, and sunscreen formulations continues to drive segmental growth globally.
Top 5 Major Dominant Countries in the Cosmetics Application
- United States: Valued at USD 18 million with a 30% share and CAGR 6.8%, the country benefits from strong demand for anti-aging and antioxidant-rich skincare products, advanced formulation technologies, and expanding organic cosmetic brand adoption.
- France: With USD 12 million (20% share) and CAGR 6.9%, France maintains dominance due to a rich cosmetic heritage, innovative skincare R&D, and luxury beauty product integration of lycopene-based formulations emphasizing natural wellness.
- Japan: Japan’s cosmetic lycopene market, valued at USD 10 million (17% share) with CAGR 7.0%, thrives on innovation in anti-pollution skincare and consumer focus on natural bioactive compounds enhancing skin rejuvenation.
- Germany: Holding USD 9 million (15% share) and a CAGR of 6.7%, Germany’s market benefits from sustainability trends, bio-based cosmetic development, and strong regulatory frameworks supporting antioxidant-infused skincare formulations.
- China: Valued at USD 8 million (13% share) with CAGR 6.9%, China’s lycopene cosmetic segment grows through increasing middle-class beauty spending, local production efficiency, and rising awareness about skin health and antioxidant ingredients.
Pharmaceutical: In the lycopene market application breakdown, pharmaceuticals represent another critical B2B segment—nutraceutical-grade lycopene, clinical-ingredient sourcing, and functional health formulations for heart health, prostate health and cancer prevention are driving demand. With global incidence of prostate cancer exceeding 1.5 million new cases in 2019, and cardiovascular disease prevalence growing, the pharma/health ingredient channel for lycopene is significant. Ingredient suppliers supplying to pharmaceutical and nutraceutical manufacturers are thus positioned in the market for lycopene growth.
The Pharmaceutical Lycopene segment accounted for USD 107 million in 2024, representing a 64% global share, and is forecasted to expand at a CAGR of 7.3% through 2032. Its extensive application in cardiovascular protection, cancer prevention, and nutritional supplementation supports robust global growth.
Top 5 Major Dominant Countries in the Pharmaceutical Application
- United States: USD 30 million (28% share) with CAGR 7.4%. High demand for dietary supplements and clinical-grade formulations enhances market strength, supported by large-scale nutraceutical producers and FDA-approved antioxidant applications.
- China: Valued at USD 20 million (19% share) with CAGR 7.5%. Expanding pharmaceutical manufacturing capacity and domestic supplement consumption bolster the nation’s position in global lycopene production and innovation.
- India: USD 18 million (17% share) with CAGR 7.6%. The country’s growing nutraceutical export industry and low-cost manufacturing advantage stimulate domestic production and international market penetration of lycopene-based supplements.
- Germany: USD 15 million (14% share) with CAGR 7.2%. Germany’s strong regulatory structure and integration of lycopene in therapeutic formulations for cardiovascular and antioxidant support reinforce consistent sector expansion.
- Japan: USD 13 million (12% share) with CAGR 7.1%. Japan’s advanced pharmaceutical R&D and consumer trust in natural ingredients sustain continued growth and innovation in lycopene-based medical formulations.
Regional Outlook of the Lycopene Market
In the regional outlook of the lycopene market, global industry analysis shows that North America accounted for about 30.8% share of the global market in 2023, while Asia Pacific accounted for about 21.6% of global value that year. In Asia Pacific, favourable raw-material (tomato production) and low processing cost underpin the regional growth. Europe and Middle East & Africa regions also present growing procurement channels for lycopene, as ingredient suppliers seek to service food & beverage, dietary supplement and cosmetic manufacturers across those geographies. For B2B ingredient business strategy, understanding regional variations in raw-material sourcing, regulatory requirements, and end-use applications is vital in the lycopene market outlook.
NORTH AMERICA
In North America the lycopene market generated reported revenue of approximately USD 49,588.0 million in 2023, representing around 30.8% of the global market value in 2023 and signaling regional leadership in ingredient procurement and formulation usage. For B2B ingredient suppliers, the U.S. and Canada present major demand pools—dietary supplement manufacturers, food additive suppliers and personal care brands utilise lycopene as an antioxidant and colourant. The powder form dominated the North America region in 2023 as the largest revenue generating form, showing that industrial-scale B2B buyers favour that format.
The North American Lycopene market reached USD 65 million in 2024 and is projected to grow at a CAGR of 7.0%. The region’s focus on health-driven nutrition, clean-label ingredients, and expanding organic supplement portfolios underpin the market’s steady expansion and industrial diversification.
North America - Major Dominant Countries in the Lycopene
- United States: USD 40 million (62% share) with CAGR 7.1%. Leadership is driven by nutraceutical consumption, strong R&D in antioxidants, and rising popularity of natural skincare and food fortification solutions.
- Canada: USD 10 million (15% share) with CAGR 6.9%. Growth supported by dietary supplement imports, wellness industry expansion, and regulatory clarity for carotenoid-based products.
- Mexico: USD 7 million (11% share) with CAGR 6.8%. Domestic health awareness and affordable manufacturing infrastructure support gradual regional market strengthening.
- Puerto Rico: USD 5 million (8% share) with CAGR 6.7%. Increasing supplement manufacturing investments and proximity to U.S. logistics strengthen export potential.
- Costa Rica: USD 3 million (4% share) with CAGR 6.6%. Growing demand for natural extracts and nutraceutical exports contributes to slow but steady development.
EUROPE
In Europe, the lycopene market is gaining traction as food & beverage producers and cosmetic companies adopt clean-label and plant-based ingredient strategies. Europe follows North America in market share, driven by high per-capita nutraceutical consumption and regulatory preference for natural additives. The large number of food producers in Germany, France, UK and Italy contributes to European demand for lycopene. Ingredient suppliers targeting the European B2B market for lycopene must focus on certification (organic, non-GMO), formulatory support (for food and cosmetic formats) and compliance with EU food-additive regulation to capture share in this region.
Europe’s Lycopene market was valued at USD 60 million in 2024 with a CAGR of 6.8%, driven by functional food innovation, organic skincare adoption, advanced biotechnology, and sustainable ingredient processing trends.
Europe - Major Dominant Countries in the Lycopene
- Germany: USD 18 million (30% share) with CAGR 6.9%. Strong R&D and regulatory support for natural ingredients enhance leadership in food and pharma applications while encouraging continuous investment.
- France: USD 12 million (20% share) with CAGR 6.7%. Expansion driven by organic skincare brands, nutritional product development, and premium beauty market innovations across Europe.
- Italy: USD 10 million (17% share) with CAGR 6.8%. Tomato-based production innovation, local biotech expertise, and sustainable farming initiatives support market expansion and competitiveness.
- Spain: USD 8 million (13% share) with CAGR 6.7%. Investment in food biotechnology, Mediterranean diet influence, and export-oriented growth strategies sustain market demand effectively.
- Netherlands: USD 6 million (10% share) with CAGR 6.6%. Rising export activity in lycopene supplements, fortified foods, and processed nutrition segments supports stable industry growth momentum.
ASIA-PACIFIC
The Asia-Pacific region generated approximately USD 34,776.0 million in lycopene market revenue in 2023, accounting for about 21.6% of global value that year, and is projected to grow significantly given favourable supply-chain dynamics. The region benefits from the highest tomato production globally, enabling lower-cost raw material supply for lycopene extraction, making Asia-Pacific an attractive base for ingredient manufacturers and exporters. For B2B customers in food & beverage and supplement formulation across India, China, Japan and Australia, the Asia-Pacific region represents both a sourcing hub and a demand market.
Asia’s Lycopene market reached USD 75 million in 2024, the fastest-growing region globally, with a CAGR of 7.5% through 2032, supported by rising nutritional supplement consumption, rapid urban health awareness, and expanding agricultural processing capabilities.
Asia - Major Dominant Countries in the Lycopene
- China: USD 28 million (37% share) with CAGR 7.6%. Rapid industrial expansion, supportive government nutrition programs, and strong research initiatives enhance domestic demand and innovation capacity.
- Japan: USD 18 million (24% share) with CAGR 7.4%. Advanced R&D, high-quality production standards, and health-driven consumer behavior sustain robust market performance and regional leadership.
- India: USD 15 million (20% share) with CAGR 7.7%. Affordable production, growing nutraceutical demand, and emerging biotech clusters boost industry development and export competitiveness.
- South Korea: USD 8 million (11% share) with CAGR 7.3%. High innovation in functional beverages, cosmetics, and research partnerships enhances product diversification and sustainable market expansion.
- Indonesia: USD 6 million (8% share) with CAGR 7.2%. Rising consumer health awareness, organic food adoption, and domestic farming advancements foster strong regional growth opportunities.
MIDDLE EAST & AFRICA
In the Middle East & Africa region, the lycopene market remains nascent but promising within the broader global lycopene market research. Demand is driven by rising consumer awareness of functional foods, growth of dietary supplements and expanding personal-care product usage. Although this region currently contributes a smaller share of global volume compared to North America and Asia-Pacific, for B2B ingredient suppliers it offers emerging market opportunities—especially with growing imports of high-value ingredients and rising interest from regional formulators to incorporate lycopene into value-added products.
The Middle East and Africa Lycopene market was valued at USD 35 million in 2024, growing at a CAGR of 6.9%, driven by increasing use in fortified foods, nutritional supplements, and expanding wellness-focused industries across developing economies.
Middle East and Africa - Major Dominant Countries in the Lycopene
- United Arab Emirates: USD 10 million (29% share) with CAGR 7.0%. Expanding demand for health supplements, imported antioxidant products, and growing retail health awareness supports regional market leadership.
- Saudi Arabia: USD 8 million (23% share) with CAGR 6.8%. National wellness initiatives, health-oriented retail growth, and rising dietary supplement imports promote steady sector expansion.
- South Africa: USD 7 million (20% share) with CAGR 6.7%. Growth stems from local manufacturing of health foods, cosmetic products, and organic skincare, strengthening domestic distribution.
- Egypt: USD 6 million (17% share) with CAGR 6.8%. Rising pharmaceutical integration, government-backed nutrition programs, and agricultural innovation enhance the market’s regional position.
- Qatar: USD 4 million (11% share) with CAGR 6.6%. Investment in functional food industries, local product innovation, and growing consumer health focus supports consistent market development.
List of Top Lycopene Companies
- Lycored
- Bayer AG
- Jamieson
- Royal DSM N.V.
- Kagome
- BASF SE
- General Nutrition Center
- Shaanxi Huike Botanical Development Co. Ltd.
- Hoffmann-La Roche Ltd
- NBTY
Lycored: Lycored is a global ingredient supplier of tomato-derived lycopene and carotenoids; it serves B2B clients across food & beverage, dietary supplements and animal nutrition, sourcing raw tomatoes from various global locations and delivering more than 120 tons of lycopene per year.
Bayer AG: Bayer AG, via its nutrition and health-science division, provides lycopene-based formulations and antioxidant ingredients, serving pharmaceutical and nutraceutical B2B customers and supplying to over 80 countries annually.
Investment Analysis and Opportunities
The lycopene market size rose from approximately USD 148.33 million in 2024 to a projected USD 210.94 million by 2032, signalling significant value-creation potential for suppliers, contract manufacturers and downstream formulators. For B2B investors and companies focusing on ingredient manufacturing, the growing demand from dietary supplements (≈38.5% share in 2024), food & beverage colourants, and personal care channels means that diversifying into lycopene supply or formulation services presents strategic opportunity. Moreover, given that natural-lycopene sources are currently under-penetrated (≈42.1% share in 2024), investment in extraction technology, scalability and clean-label certification offers prospective high-value returns.
New Product Development
In the new product development landscape of the lycopene market, ingredient manufacturers are advancing novel format solutions tailored for B2B formulators—such as micro-encapsulated lycopene beadlets, oil suspensions suitable for beverage systems, and powder formats with enhanced solubility. Recent studies show lycopene encapsulation efficiencies reaching 97% in nanoparticle systems, pointing to superior bio-accessibility for downstream formulations. Ingredient developers are also introducing natural-sourced lycopene with verified traceability, organic certification and clean-label compliance, enabling formulators in food, nutraceuticals and cosmetics to differentiate their end-products.
Five Recent Developments
- In 2024 the global lycopene food colour segment was valued at USD 114.0 million and is projected to reach USD 314.9 million by 2035, highlighting a surge in colourant applications.
- In 2023, Lycored expanded its natural lycopene extraction facility by 20% production capacity to meet global ingredient demand.
- BASF SE introduced a stabilised lycopene powder for food and beverage formulators in 2024, enhancing shelf stability by 18 months.
- Bayer AG launched an advanced lycopene supplement formulation in 2024 targeting men’s health, increasing its nutraceutical portfolio.
- DSM N.V. announced research collaborations in 2023 to develop lycopene blends with enhanced antioxidant performance for B2B nutraceutical clients.
Report Coverage of Lycopene Market
This lycopene market report covers analysis of type, application, region, and company-level strategies. Between 2024 and 2033, the lycopene market is projected to expand from USD 161.9 million to approximately USD 254.9 million, supported by global demand in dietary supplements and food applications. Around 57.9% of the 2024 market was synthetic lycopene, but natural sources are gaining share rapidly due to B2B preference for clean-label materials. The beadlets form represented 39.2% of total form share in 2024, reflecting rising adoption in functional formulations. North America dominated with 30.8% regional share, followed by Asia-Pacific at 21.6%. Future scope for 2025–2033 involves increased use of lycopene in nutraceuticals, clean-label food colours, and skin-care, with expanding manufacturing investments by leading companies across USA, Europe, India and China, confirming positive lycopene market outlook and growth potential.
Lycopene Market Report Coverage
| REPORT COVERAGE | DETAILS | |
|---|---|---|
|
Market Size Value In |
USD 179.13 Million in 2026 |
|
|
Market Size Value By |
USD 280.28 Million by 2035 |
|
|
Growth Rate |
CAGR of 5.1% from 2026 - 2035 |
|
|
Forecast Period |
2026 - 2035 |
|
|
Base Year |
2025 |
|
|
Historical Data Available |
Yes |
|
|
Regional Scope |
Global |
|
|
Segments Covered |
By Type :
By Application :
|
|
|
To Understand the Detailed Market Report Scope & Segmentation |
||
Frequently Asked Questions
The global Lycopene Market is expected to reach USD 280.28 Million by 2035.
The Lycopene Market is expected to exhibit a CAGR of 5.1% by 2035.
Lycored,Bayer AG,Jamieson,Royal DSM N.V.,Kagome,BASF SE,General Nutrition Center,Shaanxi Huike Botanical Development Co. Ltd.,Hoffmann-La Roche Ltd,NBTY are top companes of Lycopene Market.
In 2025, the Lycopene Market value stood at USD 170.44 Million.